G35.C

Clinical Causes: The precise cause of SPMS remains unknown but is believed to involve an ongoing inflammatory process within the central nervous system. Chronic immune system activity targeting myelin, the protective sheath surrounding nerve fibers, leads to nerve damage. Genetic predispositions may contribute to susceptibility. Environmental factors such as vitamin D deficiency, smoking, and certain infections have been linked to MS progression. Age-related changes and cumulative damage from earlier relapses can also influence disease progression.

Key Symptoms: Persistent neurological decline with worsening physical and cognitive functions. Chronic fatigue that does not improve with rest. Muscle weakness or stiffness, especially in the limbs. Loss of coordination and balance issues. Numbness or tingling sensations in various parts of the body. Problems with vision, such as blurred or double vision, which may become more persistent. Difficulty with walking or mobility, sometimes leading to increased dependence. Bladder and bowel dysfunction, including urgency or incontinence. Cognitive impairments such as memory problems, difficulty concentrating, and reduced processing speed. Spasticity, or involuntary muscle contractions, may also occur.

Diagnosis Path: Diagnosis of SPMS involves a combination of medical history, neurological examinations, and diagnostic tests. Key components include: - Clinical history noting the progression of symptoms over time. - Magnetic Resonance Imaging (MRI) scans revealing ongoing lesions and brain or spinal cord changes. - Evoked potentials tests to assess nerve pathway responses. - Laboratory analysis of cerebrospinal fluid, which may reveal abnormalities suggestive of MS. - Differential diagnosis to rule out other conditions that mimic MS symptoms. It’s important to distinguish SPMS from other stages of MS for appropriate management.

Treatment Protocols: While there is no cure for SPMS at present, various strategies aim to slow progression and manage symptoms. These include: - Disease-modifying therapies (DMTs) specifically approved for progressive MS to reduce disease activity. - Corticosteroids during active relapses to reduce inflammation. - Physical therapy to maintain mobility and manage spasticity. - Occupational therapy to assist with daily activities. - Symptom-specific medications, such as muscle relaxants, bladder medications, and pain relievers. - Lifestyle modifications focusing on exercise, diet, and stress management. - Regular monitoring by healthcare providers to adjust treatments as needed. Research continues into new therapies targeting disease progression and neuroprotection, offering hope for future advancements.